Despite unchanged expression of SREBP-1c mRNA after treatment with BZ, levels of PPARgamma mRNA were considerably reduced, being crucial to the lower hepatic triglycerides and liver steatosis found in this treated group. The gene discussed is PPARG; the disease is fatty liver disease.